Information and advocacy matters for patients with progeria and processing-deficient progeroid laminopathies (PDPL).
These tools help support getting patients diagnosed with these ultra-rare diseases onto Zokinvy.
IMPORTANT SAFETY INFORMATION
ZOKINVY is contraindicated in patients taking:
INDICATION AND USAGE
ZOKINVY is indicated in adult and pediatric patients 12 months of age and older with a body surface area (BSA) of 0.39 m2 and above: